Hyaluronan inhibits akt, leading to nuclear factor-κB down-regulation in lipopolysaccharide-stimulated U937 macrophages

Journal of Pharmacological Sciences

Volumn 115, Issue 4, 2011, Pages 509-515

  Yasuda, Tadashi ^a  

^a TENRI UNIVERSITY   (Japan)

Author keywords

Akt; Hyaluronan; Intercellular adhesion molecule 1; Lipopolysaccharide; Nuclear factor B

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; BACTERIUM LIPOPOLYSACCHARIDE; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR RELA;

ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MACROPHAGE; PROTEIN INTERACTION; RECEPTOR DOWN REGULATION;

EID: 79955039886     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10244FP     Document Type: Article

References (45)

1. Baldwin AS Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-683.
2. Finco TS, Baldwin AS Jr. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity. 1995;3:263-272.
3. Bellacosa A, Testa JR, Staal SP, Tsichlis PN. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science. 1991;254:274-277. (Pubitemid 21917339)
4. Coffer PJ, Woodget JR. Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur J Biochem. 1991;201:475-481.
5. Downward J. Ras signalling and apoptosis. Curr Opin Genet Dev. 1998;8:49-54. (Pubitemid 28122140)
6. Marte BM, Downward J. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci. 1997;22:355-358.
7. Franke TF, Kaplan DR, Cantley LC. PI3K: downstream AKTion blocks apoptosis. Cell. 1997;88:435-437. (Pubitemid 27154408)
8. Downward J. Lipid-regulated kinases: some common themes at last. Science. 1998;279:673-674. (Pubitemid 28144538)
9. Fruman DA, Meyers RE, Cantley LC. Phosphoinositide kinases. Annu Rev Biochem. 1998;67:481-507. (Pubitemid 28411136)
10. Hawkins PT, Welch H, McGregor A, Eguinoa A, Gobert S, Krugmann S, et al. Signalling via phosphoinositide 3OH kinases. Biochem Soc Trans. 1997;25:1147-1151.
11. Kane LP, Shapiro VS, Stokoe D, Weiss A. Induction of NF-κB by the Akt/PKB kinase. Curr Biol. 1999;9:601-604.
12. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 1999;401:82-85.
13. Romashokova JA, Makarov SS. NF-κB is a target of AKT in antiapoptotic PDGF signalling. Nature. 1999;401:86-90.
14. Sizemore N, Leung S, Stark GR. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit. Mol Cell Biol. 1999;19:4798-4805. (Pubitemid 29289518)
15. Julovi SM, Yasuda T, Shimizu M, Hiramitsu T, Nakamura T. Inhibition of interleukin-1β-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage. Arthritis Rheum. 2004;50:516-525. (Pubitemid 38198835)
16. Shimizu M, Yasuda T, Nakagawa T, Yamashita E, Julovi SM, Hiramitsu T, et al. Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines. J Rheumatol. 2003;30:1164-1172. (Pubitemid 36666336)
17. Hiramitsu T, Yasuda T, Ito H, Shimizu M, Julovi SM, Kakinuma T, et al. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1β-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-κB and p38. Rheumatology (Oxford). 2006;45:824-832. (Pubitemid 43985370)
18. Yasuda T. Hyaluronan inhibits cytokine production by lipopolysaccharide- stimulated U937 macrophages through down-regulation of NF-κB via ICAM-1. Inflamm Res. 2007;56:246-253. (Pubitemid 47026293)
19. Neumann A, Schinzel, R, Palm D, Riederer P, Muench G. High molecular weight hyaluronic acid inhibits advanced glycation end product-induced NF-κB activation and cytokine expression. FEBS Lett. 1999;453:283-287. (Pubitemid 29326664)
20. Hu HM, Tian Q, Baer M, Spooner CJ, Williams SC, Johnson PF, et al. The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1. J Biol Chem. 2000;275: 16373-16381. (Pubitemid 30366955)
21. Monick MM, Carter AB, Flaherty DM, Peterson MW, Hunninghake GW. Protein kinase Cξ plays a central role in activation of the p42/44 mitogen-activated protein kinase by endotoxin in alveolar macrophages. J Immunol. 2000;165:4632-4639.
22. Monick MM, Carter AB, Robeff PK, Flaherty DM, Peterson MW, Hunninghake GW. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of β-catenin. J Immunol. 2001;166:4713-4720. (Pubitemid 32233759)
23. Li X, Tupper JC, Bannerman DD, Winn RK, Rhodes CJ, Harlan JM. Phosphoinositide 3 kinase mediates Toll-like receptor 4- induced activation of NF-κB in endothelial cells. Infect Immun. 2003;71:4414-4420. (Pubitemid 36919907)
24. Nilsson K, Forsbeck K, Gidlund M, Sundstrom C, Totterman T, Sallstrom J, et al. Surface characteristics of the U-937 human histiocytic lymphoma cell line: specific changes during inducible morphologic and functional differentiation in vitro. Haematol Blood Transfus. 1981;26:215-221.
25. Yasuda T, Shimizu M, Nakagawa T, Julovi SM, Nakamura T. Matrix metalloproteinase production by COOH-terminal heparin-binding fibronectin fragment in rheumatoid synovial cells. Lab Invest. 2003;83:153-162. (Pubitemid 36255361)
26. Yasuda T, Julovi SM, Hiramitsu T, Yoshida M, Nakamura T. Requirement of mitogen-activated protein kinase for collagenase production by the fibronectin fragment in human articular chondrocytes in culture. Mod Rheumatol. 2004;14:54-60. (Pubitemid 40796161)
27. Penttinen MA, Holmberg CI, Sistonen L, Granfors K. HLA-B27 modulates nuclear factor κB activation in human monocytic cells exposed to lipopolysaccharide. Arthritis Rheum. 2002;46:2172-2180.
28. Dahl LB, Dahl IM, Laurent AE, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 1985;44:817-822. (Pubitemid 16222234)
29. Brown K, Claudio E, Siebenlist U. NF-κB. In: Smolen JS, Lipsky PE, editors. Targeted therapies in rheumatology. London: Martin Dunitz; 2003. p. 381-401.
30. Reddy SA, Huang JH, Liao WS. Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFκB and AP-1 activation. J Biol Chem. 1997;272:29167- 29173. (Pubitemid 27498207)
31. Reddy SA, Huang JH, Liao WS. Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-κB activation. J Immunol. 2000;164:1355-1363. (Pubitemid 30067249)
32. Handel ML, McMorrow LB, Gravallese EM. Nuclear factorkappa B in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum. 1995;38:1762-1770.
33. Marok R, Winyard PG, Coumbe A, Kus ML, Gaffney K, Blades S, et al. Activation of the transcription factor nuclear factor-κB in human inflamed synovial tissue. Arthritis Rheum. 1996;39:583-591. (Pubitemid 26118035)
34. Benito MJ, Murphy E, Murphy EP, van den Berg WB, FitzGelard O, Bresnihan B. Increased synovial tissue NF-κB1 expression at sites adjacent to the cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum. 2004;50:1781-1787.
35. Fujisawa K, Aono H, Hasunuma T, Yamamoto K, Mita S, Nishioka K. Activation of transcription factor NF-κB in human synovial cells in response to tumor necrosis factor α. Arthritis Rheum. 1996;39:197-203. (Pubitemid 26065259)
36. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell. 1996;85:307-310. (Pubitemid 26160702)
37. Mima T, Saeki Y, Ohshima S, Nishimoto N, Matsushita M, Shimizu M, et al. Transfer of rheumatoid arthritis into severe combined immunodeficient mice. The pathogenetic implications of T cell populations oligoclonally expanding in the rheumatoid joints. J Clin Invest. 1995;96:1746-1758.
38. Burger D, Dayer JM. The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction. Arthritis Res. 2002;4 Suppl 3:S169-S176.
39. McInnes IB, Leung BP, Liew FY. Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells. Arthritis Res. 2000;2:374-378.
40. Dai S-M, Matsuno H, Nakamura H, Nishioka K, Yudoh K. Interleukin-18 enhances monocyte tumor necrosis factor α and interleukin-1β production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum. 2004;50:432-443. (Pubitemid 38198827)
41. Foey A, Green P, Foxwell B, Feldmann M, Brennan F. Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K: implications for rheumatoid arthritis. Arthritis Res. 2002;4:64-70. (Pubitemid 34100491)
42. Kim KW, Cho ML, Park MK, Yoon CH, Park SH, Lee SH, et al. Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor κB-dependent pathway in patients with rheumatoid arthritis. Arthritis Res Ther. 2005;7: R139-R148.
43. Hwang SY, Kim JY, Kim KW, Park MK, Moon Y, Kim WU, et al. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and PI3-kinase/Akt-dependent pathways. Arthritis Res Ther. 2004;6:R120-R128.
44. Yang P-Y, Rui Y-C, Li K. Expression of intercellular adhesion molecule-1 in U937 foam cells and inhibitory effect of imperatorin. Acta Pharmacol Sin. 2002;23:327-330. (Pubitemid 34266590)
45. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, et al. Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis. 2002;61:804-809.